WebSite Macau: October 2016

Friday, October 28, 2016

Nazovell

Nazovell may be available in the countries listed below.

Ingredient matches for Nazovell

Ketoprofen

Ketoprofen is reported as an ingredient of Nazovell in the following countries:

Indonesia

International Drug Name Search

Dompenyl

Dompenyl may be available in the countries listed below.

Ingredient matches for Dompenyl

Domperidone

Domperidone is reported as an ingredient of Dompenyl in the following countries:

Philippines

International Drug Name Search

Fragmin

Fragmin is a brand name of dalteparin, approved by the FDA in the following formulation(s):

FRAGMIN (dalteparin sodium - injectable; subcutaneous)

Manufacturer: EISAI INC

Approval date: December 22, 1994

Strength(s): 2,500IU/0.2ML (12,500IU/ML)

Manufacturer: EISAI INC

Approval date: March 18, 1996

Strength(s): 5,000IU/0.2ML (25,000IU/ML)

Manufacturer: EISAI INC

Approval date: January 30, 1998

Strength(s): 10,000IU/ML (10,000IU/ML)

Manufacturer: EISAI INC

Approval date: April 4, 2002

Strength(s): 7,500IU/0.3ML (25,000IU/ML), 95,000IU/3.8ML (25,000IU/ML) ^[RLD], 95,000IU/9.5ML (10,000IU/ML)

Manufacturer: EISAI INC

Approval date: May 1, 2007

Strength(s): 10,000IU/0.4ML (25,000IU/ML), 12,500IU/0.5ML (25,000IU/ML), 15,000IU/0.6ML (25,000IU/ML), 18,000IU/0.72ML (25,000IU/ML)

Has a generic version of Fragmin been approved?

No. There is currently no therapeutically equivalent version of Fragmin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Fragmin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Fragmin.

Ingredient matches for Zodep

Citalopram

Citalopram is reported as an ingredient of Zodep in the following countries:

Dominican Republic

International Drug Name Search

Thursday, October 27, 2016

Ferriprox

Ferriprox is a brand name of deferiprone, approved by the FDA in the following formulation(s):

FERRIPROX (deferiprone - tablet; oral)

Manufacturer: APOPHARMA INC

Approval date: October 14, 2011

Strength(s): 500MG ^[RLD]

Has a generic version of Ferriprox been approved?

No. There is currently no therapeutically equivalent version of Ferriprox available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ferriprox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Ferriprox.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

Exclusivity expiration dates:
- October 14, 2016 - NEW CHEMICAL ENTITY
- October 14, 2018 - ORPHAN DRUG EXCLUSIVITY

Ingredient matches for Nyaderm

Nystatin

Nystatin is reported as an ingredient of Nyaderm in the following countries:

Canada

International Drug Name Search

Nexiam IV

Nexiam IV may be available in the countries listed below.

Ingredient matches for Nexiam IV

Esomeprazole

Esomeprazole sodium (a derivative of Esomeprazole) is reported as an ingredient of Nexiam IV in the following countries:

South Africa

International Drug Name Search

Closure of Colostomy Medications

See also: Gastrointestinal Surgery

Drugs associated with Closure of Colostomy

The following drugs and medications are in some way related to, or used in the treatment of Closure of Colostomy. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Drug List:

Artiss

Tisseel

Nifedipin

Nifedipin may be available in the countries listed below.

Ingredient matches for Nifedipin

Nifedipine

Nifedipine is reported as an ingredient of Nifedipin in the following countries:

Croatia (Hrvatska)

Georgia

Romania

Serbia

International Drug Name Search

Wednesday, October 26, 2016

Sutriptan

Sutriptan may be available in the countries listed below.

Ingredient matches for Sutriptan

Sumatriptan

Sumatriptan succinate (a derivative of Sumatriptan) is reported as an ingredient of Sutriptan in the following countries:

Greece

International Drug Name Search

Sucrets

Ingredient matches for Sucrets

Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Sucrets in the following countries:

United States

Dyclonine

Dyclonine hydrochloride (a derivative of Dyclonine) is reported as an ingredient of Sucrets in the following countries:

Israel

International Drug Name Search

Deltaderm Demadex

Deltaderm Demadex may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Deltaderm Demadex

Amitraz

Amitraz is reported as an ingredient of Deltaderm Demadex in the following countries:

Australia

International Drug Name Search

Dicyclomine Hydrochloride

Ingredient matches for Dicyclomine Hydrochloride

Dicycloverine

Dicycloverine hydrochloride (a derivative of Dicycloverine) is reported as an ingredient of Dicyclomine Hydrochloride in the following countries:

United States

International Drug Name Search

Hydrocortisone Ifet

Hydrocortisone Ifet may be available in the countries listed below.

Ingredient matches for Hydrocortisone Ifet

Hydrocortisone

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Hydrocortisone Ifet in the following countries:

Greece

International Drug Name Search

Neotri

Neotri may be available in the countries listed below.

Ingredient matches for Neotri

Triamterene

Triamterene is reported as an ingredient of Neotri in the following countries:

Germany

Xipamide

Xipamide is reported as an ingredient of Neotri in the following countries:

Germany

International Drug Name Search

Zerobac

Zerobac may be available in the countries listed below.

Ingredient matches for Zerobac

Erythromycin

Erythromycin is reported as an ingredient of Zerobac in the following countries:

Bangladesh

International Drug Name Search

Stiefotrex

Stiefotrex may be available in the countries listed below.

Ingredient matches for Stiefotrex

Isotretinoin

Isotretinoin is reported as an ingredient of Stiefotrex in the following countries:

Greece

International Drug Name Search

Tuesday, October 25, 2016

Sarmasol

Sarmasol may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sarmasol

Sarmazenil

Sarmazenil is reported as an ingredient of Sarmasol in the following countries:

Switzerland

International Drug Name Search

Zantac 150

See also: Generic Zantac, Generic Zantac 300

Zantac 150 is a brand name of ranitidine, approved by the FDA in the following formulation(s):

ZANTAC 150 (ranitidine hydrochloride - tablet; oral)

Manufacturer: GLAXOSMITHKLINE

Approval date: June 9, 1983

Strength(s): EQ 150MG BASE ^[AB]

Has a generic version of Zantac 150 been approved?

Yes. The following products are equivalent to Zantac 150:

ranitidine hydrochloride tablet; oral

Manufacturer: AMNEAL PHARMS NY

Approval date: October 13, 2006

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: APOTEX

Approval date: September 12, 1997

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: DR REDDYS LABS INC

Approval date: July 27, 2005

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: GLENMARK GENERICS

Approval date: November 19, 2008

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: IVAX SUB TEVA PHARMS

Approval date: September 30, 1998

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: MYLAN

Approval date: August 22, 1997

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: PAR PHARM

Approval date: January 28, 1999

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: SANDOZ

Approval date: August 29, 1997

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: TEVA

Approval date: July 31, 1997

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: WATSON LABS

Approval date: October 20, 1997

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: WATSON LABS

Approval date: December 19, 2005

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: WOCKHARDT

Approval date: December 17, 1998

Strength(s): EQ 150MG BASE ^[AB]

Manufacturer: WOCKHARDT

Approval date: November 12, 2009

Strength(s): EQ 150MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zantac 150. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Zantac 150.

Ingredient matches for Nivepin

Nevirapine

Nevirapine is reported as an ingredient of Nivepin in the following countries:

Myanmar

International Drug Name Search

Zopiclone Tianping

Zopiclone Tianping may be available in the countries listed below.

Ingredient matches for Zopiclone Tianping

Eszopiclone

Zopiclone is reported as an ingredient of Zopiclone Tianping in the following countries:

China

International Drug Name Search

Monday, October 24, 2016

Dextropropoxyphène

Dextropropoxyphène may be available in the countries listed below.

Ingredient matches for Dextropropoxyphène

Dextropropoxyphene

Dextropropoxyphène (DCF) is also known as Dextropropoxyphene (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Solpirem

Solpirem may be available in the countries listed below.

Ingredient matches for Solpirem

Zolpidem

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Solpirem in the following countries:

Colombia

International Drug Name Search

Dipiridamolo

Dipiridamolo may be available in the countries listed below.

Ingredient matches for Dipiridamolo

Dipyridamole

Dipiridamolo (DCIT) is known as Dipyridamole in the US.

International Drug Name Search

Glossary

DCIT

Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Hofvan

Hofvan may be available in the countries listed below.

Ingredient matches for Hofvan

Dimemorfan

Dimemorfan phosphate (a derivative of Dimemorfan) is reported as an ingredient of Hofvan in the following countries:

Japan

International Drug Name Search

Sertra Basics

Sertra Basics may be available in the countries listed below.

Ingredient matches for Sertra Basics

Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertra Basics in the following countries:

Germany

International Drug Name Search

Difnan

Difnan may be available in the countries listed below.

Ingredient matches for Difnan

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Difnan in the following countries:

Portugal

International Drug Name Search

Ubrolexin

Ubrolexin may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ubrolexin

Cefalexin

Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Ubrolexin in the following countries:

Austria

France

Kanamycin

Kanamycin is reported as an ingredient of Ubrolexin in the following countries:

Austria

Kanamycin sulfate (a derivative of Kanamycin) is reported as an ingredient of Ubrolexin in the following countries:

France

International Drug Name Search

Sunday, October 23, 2016

Simvastatine Apotex

Simvastatine Apotex may be available in the countries listed below.

Ingredient matches for Simvastatine Apotex

Simvastatin

Simvastatin is reported as an ingredient of Simvastatine Apotex in the following countries:

Netherlands

International Drug Name Search

Sulfacetamida

Sulfacetamida may be available in the countries listed below.

Ingredient matches for Sulfacetamida

Sulfacetamide Sodium

Sulfacetamide is reported as an ingredient of Sulfacetamida in the following countries:

Colombia

International Drug Name Search

Daypro

Daypro is a brand name of oxaprozin, approved by the FDA in the following formulation(s):

DAYPRO (oxaprozin - tablet; oral)

Manufacturer: GD SEARLE

Approval date: October 29, 1992

Strength(s): 600MG ^[RLD]^[AB]

Has a generic version of Daypro been approved?

Yes. The following products are equivalent to Daypro:

oxaprozin tablet; oral

Manufacturer: APOTEX INC

Approval date: September 2, 2004

Strength(s): 600MG ^[AB]

Manufacturer: CARACO

Approval date: January 3, 2002

Strength(s): 600MG ^[AB]

Manufacturer: DR REDDYS LABS LTD

Approval date: January 31, 2001

Strength(s): 600MG ^[AB]

Manufacturer: IVAX SUB TEVA PHARMS

Approval date: May 13, 2002

Strength(s): 600MG ^[AB]

Manufacturer: MYLAN

Approval date: February 28, 2001

Strength(s): 600MG ^[AB]

Manufacturer: SANDOZ

Approval date: January 31, 2001

Strength(s): 600MG ^[AB]

Manufacturer: TEVA

Approval date: July 3, 2002

Strength(s): 600MG ^[AB]

Manufacturer: WATSON LABS

Approval date: February 9, 2001

Strength(s): 600MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Daypro. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Daypro.

Ingredient matches for Noscapine HCl Katwijk

Noscapine

Noscapine hydrochloride (a derivative of Noscapine) is reported as an ingredient of Noscapine HCl Katwijk in the following countries:

Netherlands

International Drug Name Search

Sandoz Ceftriaxone

Sandoz Ceftriaxone may be available in the countries listed below.

Ingredient matches for Sandoz Ceftriaxone

Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Sandoz Ceftriaxone in the following countries:

South Africa

International Drug Name Search

Sicatem

Sicatem may be available in the countries listed below.

Ingredient matches for Sicatem

Cisplatin

Cisplatin is reported as an ingredient of Sicatem in the following countries:

Argentina

Peru

International Drug Name Search

Miscellaneous antibiotics

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Antibiotics are drugs that can either kill an infectious bacteria or inhibit its growth. Different antibiotics work by different mechanisms and are used to treat infections caused by bacteria that are sensitive to that particular antibiotic.

Ingredient matches for Dealyd

Phloroglucinol

Phloroglucinol polymer dihydrogen phosphate (a derivative of Phloroglucinol) is reported as an ingredient of Dealyd in the following countries:

Austria

International Drug Name Search

Sulfonamides

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Sulphonamides (sulfa drugs) are one of a group of drugs derived from sulphanilamide that prevents the growth of bacteria.

Sulphonamides compete with p-aminobenzoic acid (PABA) for the enzyme dihydropteroate synthetase, which is important in the formation of folic acid that is required by the bacteria. Folic acid is required for the synthesis of precursors of DNA and RNA both in bacteria and in mammals. Mammals obtain their folic acid in their diet but bacteria need to synthesize it. Sulphonamides inhibit the growth of bacteria but do not kill them i.e. their action is bacteriostatic.

Many sulphonamides are rapidly excreted and very soluble in urine so they are used to treat infections of the urinary tract.

Ingredient matches for Weigeluo

Rosiglitazone

Rosiglitazone hydrochloride (a derivative of Rosiglitazone) is reported as an ingredient of Weigeluo in the following countries:

China

International Drug Name Search

Saturday, October 22, 2016

Sicombyl

Sicombyl may be available in the countries listed below.

Ingredient matches for Sicombyl

Salicylic Acid

Salicylic Acid is reported as an ingredient of Sicombyl in the following countries:

Belgium

Luxembourg

International Drug Name Search

Servimox

Servimox may be available in the countries listed below.

Ingredient matches for Servimox

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Servimox in the following countries:

Bangladesh

International Drug Name Search

D. H.E. 45

In the US, D.H.E. 45 (dihydroergotamine systemic) is a member of the drug class antimigraine agents and is used to treat Cluster Headaches and Migraine.

US matches:

D.H.E. 45

D.H.E. 45 injection

Ingredient matches for D.H.E. 45

Dihydroergotamine

Dihydroergotamine mesilate (a derivative of Dihydroergotamine) is reported as an ingredient of D.H.E. 45 in the following countries:

United States

International Drug Name Search

Oxendolone

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0033765-68-3

Chemical Formula

C20-H30-O2

Molecular Weight

302

Therapeutic Category

Antiandrogen

Chemical Name

Estr-4-en-3-one, 16-ethyl-17-hydroxy-, (16ß,17ß)-

Foreign Names

Oxendolonum (Latin)
Oxendolon (German)
Oxendolone (French)
Oxendolona (Spanish)

Generic Names

Oxendolone (OS: JAN, USAN)
TSAA 291 (IS: Takeda)

Brand Name

Prostetin
Takeda, Japan

International Drug Name Search

Glossary

IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Omegut

Omegut may be available in the countries listed below.

Ingredient matches for Omegut

Omeprazole

Omeprazole is reported as an ingredient of Omegut in the following countries:

Bangladesh

International Drug Name Search

Diclofenac-1A Pharma

Diclofenac-1A Pharma may be available in the countries listed below.

Ingredient matches for Diclofenac-1A Pharma

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac-1A Pharma in the following countries:

Austria

Switzerland

International Drug Name Search

DBL Sterile Dopamine

DBL Sterile Dopamine may be available in the countries listed below.

Ingredient matches for DBL Sterile Dopamine

Dopamine

Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of DBL Sterile Dopamine in the following countries:

Australia

International Drug Name Search

Dhacillin

Dhacillin may be available in the countries listed below.

Ingredient matches for Dhacillin

Ampicillin

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Dhacillin in the following countries:

Singapore

International Drug Name Search

Friday, October 21, 2016

Norfloxacine Winthrop

Norfloxacine Winthrop may be available in the countries listed below.

Ingredient matches for Norfloxacine Winthrop

Norfloxacin

Norfloxacin is reported as an ingredient of Norfloxacine Winthrop in the following countries:

France

International Drug Name Search

Natural Vitamin E

Natural Vitamin E may be available in the countries listed below.

Ingredient matches for Natural Vitamin E

Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Natural Vitamin E in the following countries:

Peru

International Drug Name Search

Valabarb

Valabarb may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Valabarb

Pentobarbital

Pentobarbital sodium salt (a derivative of Pentobarbital) is reported as an ingredient of Valabarb in the following countries:

Australia

International Drug Name Search

Dibenzepin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06AA08

CAS registry number (Chemical Abstracts Service)

0004498-32-2

Chemical Formula

C18-H21-N3-O

Molecular Weight

295

Therapeutic Category

Antidepressant, tricyclic

Chemical Name

11H-Dibenzo[b,e][1,4]diazepin-11-one, 10-[2-(dimethylamino)ethyl]-5,10-dihydro-5-methyl-

Foreign Names

Dibenzepinum (Latin)
Dibenzepin (German)
Dibenzépine (French)
Dibencepina (Spanish)

Generic Names

Dibencepina (OS: DCIT)
Dibenzepin (OS: BAN)
Dibenzépine (OS: DCF)
LW 1927 (IS)
Dibenzepine Hydrochloride (OS: USAN)
HF 1927 (IS: Sandoz)

Brand Names

Noveril retard
Novartis, Austria

Noveril
Novartis, Switzerland; Novartis, Czech Republic; Novartis, Hungary; Novartis, Israel; Novartis, Luxembourg; Novartis, Poland; Novartis, Slovakia

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sulfapyrine LA

Sulfapyrine LA may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sulfapyrine LA

Sulfamethoxypyridazine

Sulfamethoxypyridazine is reported as an ingredient of Sulfapyrine LA in the following countries:

United Kingdom

International Drug Name Search

Optiray 350

See also: Generic Optiray 240, Generic Optiray 300, Generic Optiray 320

Optiray 350 is a brand name of ioversol, approved by the FDA in the following formulation(s):

OPTIRAY 350 (ioversol - injectable; injection)

Manufacturer: MALLINCKRODT

Approval date: January 22, 1992

Strength(s): 74% ^[RLD]

Manufacturer: MALLINCKRODT

Approval date: May 28, 1998

Strength(s): 74% ^[RLD]

Has a generic version of Optiray 350 been approved?

No. There is currently no therapeutically equivalent version of Optiray 350 available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Optiray 350. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Optiray 350.

Thursday, October 20, 2016

Hypersexuality State Medications

There are currently no drugs listed for "Hypersexuality State". See Sexual Disorders.

Drug List:

Nodex

Nodex may be available in the countries listed below.

Ingredient matches for Nodex

Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Nodex in the following countries:

France

International Drug Name Search

Sulfaethoxypyridazine

In some countries, this medicine may only be approved for veterinary use.

CAS registry number (Chemical Abstracts Service)

0000963-14-4

Chemical Formula

C12-H14-N4-O3-S

Molecular Weight

294

Therapeutic Category

Antibacterial: Sulfonamid

Chemical Names

3-Ethoxy-6-sulfanilamidopyridazine

4-Amino-N-(6-ethoxy-3-pyridazinyl)-benzenesulfonamide

Benzenesulfonamide, 4-amino-N-(6-ethoxy-3-pyridazinyl)- (9CI)

N1-(6-Ethoxypyridazin-3-yl)sulphanilamide

Sulfanilamide, N(sup 1)-(6-ethoxy-3-pyridazinyl)-

Foreign Name

Sulfaethoxypyridazin (German)

Generic Names

5-25-12-00430 (IS: Beilstein)
BRN 0286161 (IS)
Cysul (IS)
EINECS 213-514-7 (IS)
N(sup 1)-(6-Ethoxy-3-pyridazinyl)sulfanilamide (IS)
S.E.Z. (IS)
Sulfaäthoxypyridazin (IS)

Brand Names

S.E.Z. (veterinary use)
Fort Dodge Animale Health, United States

S.E.Z. Drinking Water Solution (veterinary use)
Fort Dodge Animale Health, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Dolobeneurin

Dolobeneurin may be available in the countries listed below.

Ingredient matches for Dolobeneurin

Ibuprofen

Ibuprofen lysine (a derivative of Ibuprofen) is reported as an ingredient of Dolobeneurin in the following countries:

Argentina

International Drug Name Search

Querto

Querto may be available in the countries listed below.

Ingredient matches for Querto

Carvedilol

Carvedilol is reported as an ingredient of Querto in the following countries:

Germany

International Drug Name Search

Prilosec

Prilosec is a brand name of omeprazole, approved by the FDA in the following formulation(s):

PRILOSEC (omeprazole - capsule, delayed rel pellets; oral)

Manufacturer: ASTRAZENECA

Approval date: September 14, 1989

Strength(s): 20MG ^[RLD]^[AB]

Manufacturer: ASTRAZENECA

Approval date: October 5, 1995

Strength(s): 10MG ^[AB]

Manufacturer: ASTRAZENECA

Approval date: January 15, 1998

Strength(s): 40MG ^[RLD]^[AB]

PRILOSEC (omeprazole magnesium - for suspension, delayed release; oral)

Manufacturer: ASTRAZENECA

Approval date: March 20, 2008

Strength(s): EQ 10MG BASE/PACKET ^[RLD], EQ 2.5MG BASE/PACKET

Has a generic version of Prilosec been approved?

A generic version of Prilosec has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Prilosec and have been approved by the FDA:

omeprazole capsule, delayed rel pellets; oral

Manufacturer: APOTEX

Approval date: October 22, 2007

Strength(s): 10MG ^[AB], 20MG ^[AB]

Manufacturer: APOTEX

Approval date: January 21, 2009

Strength(s): 40MG ^[AB]

Manufacturer: DR REDDYS LABS

Approval date: April 17, 2009

Strength(s): 40MG ^[AB]

Manufacturer: DR REDDYS LABS LTD

Approval date: October 22, 2007

Strength(s): 10MG ^[AB], 20MG ^[AB]

Manufacturer: DR REDDYS LABS LTD

Approval date: January 21, 2009

Strength(s): 40MG ^[AB]

Manufacturer: DR REDDYS LABS LTD

Approval date: March 16, 2009

Strength(s): 10MG ^[AB], 20MG ^[AB]

Manufacturer: IMPAX LABS

Approval date: October 22, 2007

Strength(s): 10MG ^[AB], 20MG ^[AB]

Manufacturer: IMPAX LABS

Approval date: January 21, 2009

Strength(s): 40MG ^[AB]

Manufacturer: KREMERS URBAN PHARMS

Approval date: November 1, 2002

Strength(s): 10MG ^[AB], 20MG ^[AB]

Manufacturer: KREMERS URBAN PHARMS

Approval date: January 23, 2009

Strength(s): 40MG ^[AB]

Manufacturer: LEK PHARMS

Approval date: January 28, 2003

Strength(s): 10MG ^[AB], 20MG ^[AB]

Manufacturer: MYLAN

Approval date: May 29, 2003

Strength(s): 10MG ^[AB], 20MG ^[AB]

Manufacturer: MYLAN

Approval date: January 21, 2009

Strength(s): 40MG ^[AB]

Manufacturer: SANDOZ

Approval date: January 21, 2009

Strength(s): 40MG ^[AB]

Manufacturer: WATSON LABS FLORIDA

Approval date: May 30, 2008

Strength(s): 10MG ^[AB], 20MG ^[AB], 40MG ^[AB]

Note: No generic formulation of the following product is available.

omeprazole magnesium - for suspension, delayed release; oral

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prilosec. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

Pharmaceutical formulation of omeprazole
Patent 5,690,960
Issued: November 25, 1997
Inventor(s): Bengtsson; Inga Siv & Lovgren; Kurt Ingmar
Assignee(s): Astra Aktiebolag
A new oral pharmaceutical formulation containing a novel physical form of a magnesium salt of omeprazole, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.
Patent expiration dates:
- November 25, 2014
  ✓
  Patent use: PEDIATRIC USE AGES 1-2 YEARS, GERD AND EROSIVE ESOPHAGITIS
  ✓
  Drug product

Omeprazole magnesium salt form
Patent 5,900,424
Issued: May 4, 1999
Inventor(s): Kallstrom; Lars .ANG.ke & Nygren; Monica Annelie
Assignee(s): Astra Aktiebolag
A novel compound form of magnesium omeprazole useful in the manufacture of pharmaceutical formulations, the use of the product and the process for its production are described.
Patent expiration dates:
- May 4, 2016
  ✓
  Patent use: PEDIATRIC USE AGES 1-2 YEARS, GERD AND EROSIVE ESOPHAGITIS
  ✓
  Drug substance

Omeprazole process and compositions thereof
Patent 6,147,103
Issued: November 14, 2000
Inventor(s): Anousis; Nick & McManus; James W. & Banks; Benjamin Newton & Zhou; Lingwen
Assignee(s): Merck & Co., Inc.
The present invention describes an improved process for the preparation, isolation, and purification of the anti-ulcer agent omeprazole whereby the sulfide precursor pyrmetazole is reacted subsurfacely with exactly one molar equivalent of meta-chloroperoxybenzoic acid in methylene chloride or toluene solution; residual organic solvent is removed from the aqueous layer by vacuum distillation; crude product is obtained by reactive crystallization with an alkyl formate and seeding; and pure product is isolated by recrystallization in methanol-water containing aqueous NaOH by subsurface addition of aqueous acetic acid to pH 9.0, seeding, filtration, washing, and drying. Compositions of omeprazole containing no chromatographically detectable levels of residual non-alcoholic organic reaction solvent are also described.
Patent expiration dates:
- October 9, 2018
- April 9, 2019
  ✓
  Pediatric exclusivity

Crystalline form of omeprazole
Patent 6,150,380
Issued: November 21, 2000
Inventor(s): Lovqvist; Karin & Sunden; Gunnel & Noreland; David & Ymen; Ingvar
Assignee(s): Astra Aktiebolag
The present invention relates to a novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benz imidazole, known under the generic name omeprazole. Further, the present invention also relates to the use of the novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benz imidazole for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benz imidazole.
Patent expiration dates:
- November 10, 2018
- May 10, 2019
  ✓
  Pediatric exclusivity

Omeprazole process and compositions thereof
Patent 6,166,213
Issued: December 26, 2000
Inventor(s): Anousis; Nick & McManus; James W. & Banks; Benjamin Newton & Zhou; Lingwen & Liu; Hui
Assignee(s): Merck & Co., Inc.
The present invention describes an improved process for the preparation, isolation, and purification of the anti-ulcer agent omeprazole whereby the sulfide precursor pyrmetazole is reacted subsurfacely with exactly one molar equivalent of meta-chloroperoxybenzoic acid in methylene chloride or toluene solution; residual organic solvent is removed from the aqueous layer by vacuum distillation; crude product is obtained by reactive crystallization with an alkyl formate and seeding; and pure product is isolated by recrystallization in methanol-water containing aqueous NaOH by subsurface addition of aqueous acetic acid to pH 9.0, seeding, filtration, washing, and drying. Compositions of omeprazole containing no chromatographically detectable levels of residual non-alcoholic organic reaction solvent are also described.
Patent expiration dates:
- October 9, 2018
- April 9, 2019
  ✓
  Pediatric exclusivity

Omerazole process and compositions thereof
Patent 6,191,148
Issued: February 20, 2001
Inventor(s): McManus; James W. & Anousis; Nick & Banks; Benjamin Newton & Liu; Hui & Zhou; Lingwen
Assignee(s): Merck & Co., Inc.
The present invention describes an improved process for the preparation, isolation, and purification of the anti-ulcer agent omeprazole whereby the sulfide precursor pyrmetazole is reacted subsurfacely with exactly one molar equivalent of meta-chloroperoxybenzoic acid in a chlorinated aliphatic hydrocarbon or aromatic hydrocarbon solvent, such as methylene chloride or toluene; residual organic solvent is removed from the aqueous layer by vacuum distillation; crude product is obtained by reactive crystallization with an alkyl formate or formic acid solution and seeding; and pure product is isolated by recrystallization in methanol-water containing aqueous NaOH by subsurface addition of aqueous acetic acid to pH 9.0, seeding, filtration, washing, and drying. Omeprazole and compositions of omeprazole containing no chromatographically detectable levels of residual non-alcoholic organic reaction solvent and diminished levels of alcoholic solvent are also described.
Patent expiration dates:
- October 9, 2018
- April 9, 2019
  ✓
  Pediatric exclusivity

Pharmaceutical formulation comprising omeprazole
Patent 6,428,810
Issued: August 6, 2002
Inventor(s): Pontus; Bergstrand & Peter; Wang
Assignee(s): AstraZeneca AB
An enteric coated oral pharmaceutical formulation comprising as active ingredient a compound selected from the group of omeprazole, an alkaline salt of omeprazole, one of the single enantiomers of omeprazole and an alkaline salt of one of the single enantiomers of omeprazole, wherein the formulation comprises a core material that comprises the active ingredient and optionally an alkaline reacting compound, the active ingredient is in admixture with a pharmaceutically acceptable excipient, such as for instance a binding agent, and on said core material a separating layer and an enteric coating layer. A hydroxypropyl cellulose (HPC) with a specific cloud point is used in the manufacture of the claimed pharmaceutical formulations. Furthermore, the application describes the processes for their preparation and the use of the claimed formulations in medicine.
Patent expiration dates:
- November 3, 2019
  ✓
  Patent use: PEDIATRIC USE AGES 1-2 YEARS, GERD AND EROSIVE ESOPHAGITIS
  ✓
  Drug product

Related Exclusivities

Exclusivity expiration dates:
- March 20, 2011 - NEW PATIENT POPULATION
- September 20, 2011 - PEDIATRIC EXCLUSIVITY

Ingredient matches for De-Nol

Bismuthate, Tripotassium Dicitrato-

Bismuthate, Tripotassium Dicitrato- is reported as an ingredient of De-Nol in the following countries:

Georgia

Greece

Italy

Latvia

Romania

Russian Federation

Singapore

Turkey

International Drug Name Search

Skopryl

Skopryl may be available in the countries listed below.

Ingredient matches for Skopryl

Lisinopril

Lisinopril is reported as an ingredient of Skopryl in the following countries:

Bulgaria

Croatia (Hrvatska)

Serbia

Slovenia

International Drug Name Search

Nitrazen

Nitrazen may be available in the countries listed below.

Ingredient matches for Nitrazen

Ketoconazole

Ketoconazole is reported as an ingredient of Nitrazen in the following countries:

Japan

International Drug Name Search

Quinalar

Quinalar may be available in the countries listed below.

Ingredient matches for Quinalar

Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Quinalar in the following countries:

Venezuela

International Drug Name Search

Wednesday, October 19, 2016

Dysthymia Medications

Definition of Dysthymia: A disorder with a chronic depressed mood; it is a mild form of depression.

Drugs associated with Dysthymia

The following drugs and medications are in some way related to, or used in the treatment of Dysthymia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Topics under Dysthymia

Neurotic Depression (2 drugs)

Learn more about Dysthymia

Medical Encyclopedia:

Dysthymia

Harvard Health Guide:

Symptoms and treatment for Dysthymia

Drugs.com Health Center:

Depression

Drug List:

Elavil

Vanatrip

Dermovat Scalp

Dermovat Scalp may be available in the countries listed below.

Ingredient matches for Dermovat Scalp

Clobetasol

Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Dermovat Scalp in the following countries:

Finland

International Drug Name Search

Drogryl

Drogryl may be available in the countries listed below.

Ingredient matches for Drogryl

Diphenhydramine

Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Drogryl in the following countries:

Turkey

International Drug Name Search

Sove

Sove may be available in the countries listed below.

Ingredient matches for Sove

Zolpidem

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Sove in the following countries:

Myanmar

International Drug Name Search

Danferane

Danferane may be available in the countries listed below.

Ingredient matches for Danferane

Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Danferane in the following countries:

Argentina

Trimethoprim

Trimethoprim is reported as an ingredient of Danferane in the following countries:

Argentina

International Drug Name Search

Nitaxide

Nitaxide may be available in the countries listed below.

Ingredient matches for Nitaxide

Nitazoxanide

Nitazoxanide is reported as an ingredient of Nitaxide in the following countries:

Bangladesh

International Drug Name Search

Zimanel

Zimanel may be available in the countries listed below.

Ingredient matches for Zimanel

Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Zimanel in the following countries:

Italy

International Drug Name Search

Tuesday, October 18, 2016

Heparin Krka

Heparin Krka may be available in the countries listed below.

Ingredient matches for Heparin Krka

Heparin

Heparin sodium salt (a derivative of Heparin) is reported as an ingredient of Heparin Krka in the following countries:

Slovenia

International Drug Name Search

Fusariosis Medications

Drugs associated with Fusariosis

The following drugs and medications are in some way related to, or used in the treatment of Fusariosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Drug List:

Vfend

Hydrocortisel

Hydrocortisel may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Hydrocortisel

Dexamethasone

Dexamethasone 21-acetate (a derivative of Dexamethasone) is reported as an ingredient of Hydrocortisel in the following countries:

Germany

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Hydrocortisel in the following countries:

Germany

International Drug Name Search

Salbutamol Sulfate

Salbutamol Sulfate may be available in the countries listed below.

Ingredient matches for Salbutamol Sulfate

Salbutamol

Salbutamol Sulfate (JAN) is also known as Salbutamol (Rec.INN)

International Drug Name Search

Glossary

JAN	Japanese Accepted Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Droplix

Droplix may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Droplix

Dimpylate

Dimpylate is reported as an ingredient of Droplix in the following countries:

Portugal

International Drug Name Search

Hexat

Hexat may be available in the countries listed below.

Ingredient matches for Hexat

Pentazocine

Pentazocine is reported as an ingredient of Hexat in the following countries:

Japan

International Drug Name Search

Qnim

Qnim may be available in the countries listed below.

Ingredient matches for Qnim

Nimesulide

Nimesulide is reported as an ingredient of Qnim in the following countries:

Myanmar

International Drug Name Search

Monday, October 17, 2016

Strevital

Strevital may be available in the countries listed below.

Ingredient matches for Strevital

Streptomycin

Streptomycin is reported as an ingredient of Strevital in the following countries:

Romania

International Drug Name Search

Doxlin

Doxlin may be available in the countries listed below.

Ingredient matches for Doxlin

Doxycycline

Doxycycline is reported as an ingredient of Doxlin in the following countries:

Bangladesh

International Drug Name Search

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Friday, October 28, 2016

Ingredient matches for Nazovell

Ingredient matches for Dompenyl

FRAGMIN (dalteparin sodium - injectable; subcutaneous)

Has a generic version of Fragmin been approved?

Related Patents

See also...

Ingredient matches for Zodep

Thursday, October 27, 2016

FERRIPROX (deferiprone - tablet; oral)

Has a generic version of Ferriprox been approved?

Related Patents

Related Exclusivities

See also...

Ingredient matches for Nyaderm

Ingredient matches for Nexiam IV

Drugs associated with Closure of Colostomy

Drug List:

Ingredient matches for Nifedipin

Wednesday, October 26, 2016

Ingredient matches for Sutriptan

Ingredient matches for Sucrets

Ingredient matches for Deltaderm Demadex

Ingredient matches for Dicyclomine Hydrochloride

Ingredient matches for Hydrocortisone Ifet

Ingredient matches for Neotri

Ingredient matches for Zerobac

Ingredient matches for Stiefotrex

Tuesday, October 25, 2016

Ingredient matches for Sarmasol

ZANTAC 150 (ranitidine hydrochloride - tablet; oral)

Has a generic version of Zantac 150 been approved?

ranitidine hydrochloride tablet; oral

Related Patents

See also...

Ingredient matches for Nivepin

Ingredient matches for Zopiclone Tianping

Monday, October 24, 2016

Ingredient matches for Dextropropoxyphène

Ingredient matches for Solpirem

Ingredient matches for Dipiridamolo

Ingredient matches for Hofvan

Ingredient matches for Sertra Basics

Ingredient matches for Difnan

Ingredient matches for Ubrolexin

Sunday, October 23, 2016

Ingredient matches for Simvastatine Apotex

Ingredient matches for Sulfacetamida

DAYPRO (oxaprozin - tablet; oral)

Has a generic version of Daypro been approved?

oxaprozin tablet; oral

Related Patents

See also...

Scheme

ATC (Anatomical Therapeutic Chemical Classification)

CAS registry number (Chemical Abstracts Service)

Chemical Formula

Molecular Weight

Therapeutic Categories

Chemical Name

Foreign Names

Generic Names

Brand Names

Ingredient matches for Noscapine HCl Katwijk

Ingredient matches for Sandoz Ceftriaxone

Ingredient matches for Sicatem

See also

Drug List:

Ingredient matches for Dealyd

See also

Drug List:

Ingredient matches for Weigeluo

Saturday, October 22, 2016

Ingredient matches for Sicombyl

Ingredient matches for Servimox

Ingredient matches for D.H.E. 45

Scheme

CAS registry number (Chemical Abstracts Service)

Chemical Formula

Molecular Weight